Last reviewed · How we verify

NCT05406687: CANCERLESS

Cancer Prevention and Early Detection Among the Homeless Population: The Health Navigator Model

Completed NA Last updated 8 January 2024
What this trial tests

NA trial testing Health Navigator Model in Cancer in 654 participants. Completed in 29 December 2023.

Timeline
8 June 2022
Primary endpoint
29 December 2023
29 December 2023

Quick facts

Lead sponsorMedical University of Vienna
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment654
Start date8 June 2022
Primary completion29 December 2023
Estimated completion29 December 2023
Sites18 locations across Austria, United Kingdom, Greece, Spain

Drugs / interventions tested

Conditions studied

Sponsor

Medical University of Vienna

Who can join

18 and older, any sex, with Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prevention and early detection are key for the decrease of cancer-related mortality. However, socially deprived population groups don't have the privilege of unburdened access to the healthcare system. The EU-funded CANCERLESS project aims to develop an evidence-based, patient-centred innovation that reinforces patients through health education and social support and fosters timely access to primary and secondary prevention services. Based on the combination of the tested Patient Navigator Model and the Patient Empowerment Model, CANCERLESS will develop the Health Navigator Model for Europe, addressed to the underserved population.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Barriers and facilitators to health care access for people experiencing homelessness in four European countries: an exploratory qualitative study.
    Carmichael C, Schiffler T, Smith L, Moudatsou M, et al · · 2023 · cited 26× · PMID 37803317 · DOI 10.1186/s12939-023-02011-4

Verify or expand the search:

Other recruiting trials for Cancer

Currently open trials in the same condition.

Other Medical University of Vienna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05406687.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing